Xenical Should Be Pulled From Market Due To Possible Precancer Ties, Public Citizen Says
This article was originally published in The Pink Sheet Daily
Executive Summary
A petition from the advocacy group comes days after GSK receives an “approvable” letter for the obesity drug’s Rx-to-OTC switch.
You may also be interested in...
Acomplia To Launch In July In Europe For Obesity Indication
Sanofi-Aventis’ rimonabant is currently “approvable” at FDA for obesity.
Acomplia To Launch In July In Europe For Obesity Indication
Sanofi-Aventis’ rimonabant is currently “approvable” at FDA for obesity.
Glaxo's Alli Favored For OTC Weight-Loss Use By FDA Joint Panel
FDA's Nonprescription Drugs and Endocrinologic & Metabolic Drugs advisory committees voted 11-3 in favor of making Xenical available over the counter.